Profiel
Jean-Paul Leon is a Director of Biocortech SAS.
Previously, he was Chief Financial Officer and Executive Vice President of Corporate Strategy for Sanofi.
Mr. Leon has experience in the pharma environment.
Actieve functies van Jean-Paul Leon
Bedrijven | Functie | Begin |
---|---|---|
Biocortech SAS
Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Jean-Paul Leon
Bedrijven | Functie | Einde |
---|---|---|
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Biocortech SAS
Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France. | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |